Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2016-09-20 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Berenberg and Goldman Sachs – 5th German Corporate Conference
Investor Presentation Classification · 100% confidence The document is a slide deck presentation titled 'Berenberg Bank & Goldman Sachs 5th German Corporate Conference' dated 20 September 2016. It contains detailed financial outlooks, segment performance, and strategic information (e.g., acquisition of Quirónsalud) intended for investors. It is not a formal quarterly report (IR) or earnings release (ER), but rather a presentation used at an investor conference. FY 2016
2016-09-20 English
Barclays European High Yield and Leveraged Finance Conference
Investor Presentation Classification · 99% confidence The document text is structured like a presentation, indicated by the use of 'Agenda', 'Company Overview', 'Business Segments', and detailed financial slides with charts and tables. It specifically mentions being presented at the 'Barclays – High Yield and Leveraged Finance Conference' on 'September 19, 2016'. This format, which includes strategic overviews, segment breakdowns, and key financial highlights (H1/2016 figures), is characteristic of an Investor Presentation (IP) designed to communicate strategy and performance to the investment community, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). The length (44,788 chars) suggests more detail than a typical factsheet (FS) or a simple announcement (RPA/RNS).
2016-09-19 English
UBS – Best of Germany Conference
Investor Presentation Classification · 98% confidence The document text contains financial data, outlooks, segment performance details, and specific quarterly results (Q2/16 and H1/16) presented in a slide deck format (indicated by section headers like '# UBS Best of Germany Conference' and numerous tables/bullet points typical of investor presentations). It discusses an acquisition (Quirónsalud), provides financial guidance for 2016 and mid-term targets (2019), and details results across business segments (Fresenius Medical Care, Kabi, Helios, Vamed). This structure strongly suggests an Investor Presentation (IP) used to communicate detailed financial and strategic updates to investors, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). The length (33,045 chars) is substantial, ruling out RPA/RNS based on the 'MENU VS MEAL' rule for short announcements.
2016-09-14 English
Morgan Stanley – Global Healthcare Conference
Investor Presentation Classification · 98% confidence The document is titled "Morgan Stanley Global Healthcare Conference" and contains slides detailing transaction highlights (Acquisition of Quirónsalud), corporate history, market facts, financial outlook, guidance updates for 2016, mid-term targets (2019), and detailed financial results for Q2/16 and H1/16 across various business segments (Fresenius Medical Care, Kabi, Helios, Vamed). This structure—a presentation given at an external conference, summarizing recent performance and future outlook—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), which typically focuses only on the period's results announcement. Since it is a detailed presentation for investors, IP is the most appropriate classification.
2016-09-13 English
Bank of America Merrill Lynch – European Credit Loans Conference
Investor Presentation Classification · 98% confidence The document is a presentation titled 'Bank of America Merrill Lynch European Credit Conference September 7, 2016 – London'. It contains an agenda, financial highlights (Sales, EBIT, Net Income) for H1/2016 and LTM June 30, 2016, detailed segment performance (Fresenius Medical Care, Kabi, Helios, Vamed), and financial metrics like cash flow and debt ratios. This structure, focusing on presenting financial performance, strategy, and outlook to investors/analysts at a conference, strongly indicates an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER) which typically announces results, but rather a detailed presentation used for investor engagement.
2016-09-07 English
Conference Call on the Acquisition of Quirónsalud
Investor Presentation Classification · 98% confidence The document is titled 'Acquisition of Quirónsalud' and contains forward-looking statements, transaction highlights, financial outlooks, and details about a corporate action (acquisition). It explicitly mentions 'New mid-term targets for Fresenius Group as part of its FY 2016 reporting' and includes a 'Financial Calendar 2016' listing a 'Report on 3rd quarter 2016'. The content is a presentation format, discussing strategic rationale, financial impact (accretive nature, synergy targets), and operational details of the acquired entity. This structure strongly suggests an Investor Presentation (IP) used to communicate strategic moves and financial expectations to the investment community, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). It is too detailed for an RPA and too focused on strategy/transaction details for a standard ER or IR.
2016-09-06 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.